Pacer Advisors
IONS icon

Pacer Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Pacer Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-960
Closed -$45.8K – 2622
2024
Q2 		$45.8K Sell
960
-11
-1% -$451 ﹤0.01% 3213
2024
Q1 		$42.1K Buy
+971
New +$46.3K ﹤0.01% 3238
2021
Q2 		– Sell
-1,471
Closed -$66K – 1476
2021
Q1 		$66K Sell
1,471
-1,410
-49% -$78.6K ﹤0.01% 1398
2020
Q4 		$163K Buy
2,881
+1,080
+60% +$53.8K ﹤0.01% 1267
2020
Q3 		$85K Buy
+1,801
New +$100K ﹤0.01% 1272
2019
Q3 		– Sell
-20,333
Closed -$1.31M – 1187
2019
Q2 		$1.31M Buy
+20,333
New +$1.44M 0.03% 699
2019
Q1 		– Sell
-12,106
Closed -$654K – 754
2018
Q4 		$654K Buy
12,106
+6,187
+105% +$316K 0.02% 118
2018
Q3 		$305K Buy
+5,919
New +$278K 0.01% 949
2018
Q1 		– Sell
-1,982
Closed -$100K – 1085
2017
Q4 		$100K Sell
1,982
-13,979
-88% -$767K 0.01% 960
2017
Q3 		$809K Buy
15,961
+2,002
+14% +$105K 0.07% 403
2017
Q2 		$710K Buy
13,959
+922
+7% +$42.9K 0.07% 409
2017
Q1 		$524K Buy
13,037
+2,085
+19% +$93.6K 0.06% 462
2016
Q4 		$524K Buy
10,952
+605
+6% +$23.9K 0.07% 376
2016
Q3 		$379K Buy
10,347
+710
+7% +$22.2K 0.06% 484
2016
Q2 		$225K Buy
9,637
+8,049
+507% +$260K 0.04% 731
2016
Q1 		$64K Buy
1,588
+79
+5% +$3.21K 0.01% 746
2015
Q4 		$93K Buy
+1,509
New +$81.4K 0.02% 623

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Pacer Advisors's IONS Position: Q3 2024 in Review

Pacer Advisors sold out of Ionis Pharmaceuticals (IONS) in Q3 2024, closing a stake of 960 shares — an estimated $45.8K sold.

Pacer Advisors first reported a position in IONS in Q4 2015 and held it in 17 quarters. The position peaked at $1.31M in Q2 2019. 353 funds tracked by Wall St. Rank hold IONS as of Q3 2024.

  • Pacer Advisors reported no remaining Ionis Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Pacer Advisors sold 960 Ionis Pharmaceuticals shares in Q3 2024, an estimated $45.8K.
  • Pacer Advisors first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 17 quarters.
  • Pacer Advisors's Ionis Pharmaceuticals position peaked at $1.31M in Q2 2019.
  • 353 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2024.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.